These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11162046)

  • 1. Clinical applications of magnetic drug targeting.
    Lübbe AS; Alexiou C; Bergemann C
    J Surg Res; 2001 Feb; 95(2):200-6. PubMed ID: 11162046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
    Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
    J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
    Lübbe AS; Bergemann C; Huhnt W; Fricke T; Riess H; Brock JW; Huhn D
    Cancer Res; 1996 Oct; 56(20):4694-701. PubMed ID: 8840986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
    Morimoto Y; Natsume H
    Nihon Rinsho; 1998 Mar; 56(3):649-56. PubMed ID: 9549351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional cancer treatment with magnetic drug targeting.
    Alexiou C; Arnold W; Klein RJ; Parak FG; Hulin P; Bergemann C; Erhardt W; Wagenpfeil S; Lübbe AS
    Cancer Res; 2000 Dec; 60(23):6641-8. PubMed ID: 11118047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nanocarrier systems in cancer nanotherapy.
    Mozafari MR; Pardakhty A; Azarmi S; Jazayeri JA; Nokhodchi A; Omri A
    J Liposome Res; 2009; 19(4):310-21. PubMed ID: 19863166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo.
    Iacob G; Rotariu O; Strachan NJ; Häfeli UO
    Biorheology; 2004; 41(5):599-612. PubMed ID: 15477667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties.
    Lin BL; Shen XD; Cui S
    Biomed Mater; 2007 Jun; 2(2):132-4. PubMed ID: 18458446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia.
    Ciofani G; Riggio C; Raffa V; Menciassi A; Cuschieri A
    Med Hypotheses; 2009 Jul; 73(1):80-2. PubMed ID: 19272717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetically modulated therapeutic systems.
    Häfeli UO
    Int J Pharm; 2004 Jun; 277(1-2):19-24. PubMed ID: 15158965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic carrier method- an expectation for antitumoral therapy].
    Iacob G; Ciochină AD; Bredeţean O
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):815-21. PubMed ID: 12092246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
    Li AM; Zhang CX; Fu XP; Zhang ZW; Xue QH; Yan RM; Yi LH
    Chin Med J (Engl); 2005 May; 118(10):824-7. PubMed ID: 15989762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
    Nowicka AM; Kowalczyk A; Donten M; Krysinski P; Stojek Z
    Anal Chem; 2009 Sep; 81(17):7474-83. PubMed ID: 19663451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of drugs to cell surface receptors.
    Ríhová B
    Crit Rev Biotechnol; 1997; 17(2):149-69. PubMed ID: 9192475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.